Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sopharma AD Director's Dealing 2021

Nov 29, 2021

2543_rns_2021-11-29_b6532a22-22c3-4649-a4e5-4b347704d5ee.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014

"Sopharma" AD (the "Company") announces that it was notified by Mr. Ognian Donev, Chairman of the Board of Directors that he, executed the following transactions related to shares in the Company:

Date of the Operation Number of Unit price
transaction rights (BGN)
26.11.2021 Acquired rights 153 901 0,02
to issue warrants
26.11.2021 Acquired rights 10 000 0,02
to issue warrants
26.11.2021 Acquired rights 45 000 0,02
to issue warrants
26.11.2021 Acquired rights 6 500 0,02
to issue warrants
26.11.2021 Acquired rights 362 0,02
to issue warrants
26.11.2021 Acquired rights 300 0,02
to issue warrants
26.11.2021 Acquired rights 1 000 0,02
to issue warrants
26.11.2021 Acquired rights 444 0,02
to issue warrants
26.11.2021 Acquired rights 1 279 0,02
to issue warrants

The transfer of the above-mentioned rights was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade.

Signatures of individuals authorized to represent the Company:

Ognian Donev